EFPIA’s new report urges clearer, lifecycle-wide governance for AI in pharmaceuticals. Drawing on cross-sector insights, it calls for clarifying AI exemptions, strengthening regulator–industry dialogue, harmonizing expectations,...
Some approaches to developing pharmaceuticals are more efficient than others. Algernon Pharmaceuticals provides a perfect example of the efficient way, with a large portion of its...